Cargando…

T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment

A better understanding of early brain changes that precede loss of independence in diseases like Alzheimer's disease (AD) is critical for development of disease-modifying therapies. Quantitative MRI, such as T2 relaxometry, can identify microstructural changes relevant to early stages of pathol...

Descripción completa

Detalles Bibliográficos
Autores principales: Wearn, Alfie R., Nurdal, Volkan, Saunders-Jennings, Esther, Knight, Michael J., Madan, Christopher R., Fallon, Sean-James, Isotalus, Hanna K., Kauppinen, Risto A., Coulthard, Elizabeth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350145/
https://www.ncbi.nlm.nih.gov/pubmed/34116150
http://dx.doi.org/10.1016/j.neuroimage.2021.118214
_version_ 1783735691321016320
author Wearn, Alfie R.
Nurdal, Volkan
Saunders-Jennings, Esther
Knight, Michael J.
Madan, Christopher R.
Fallon, Sean-James
Isotalus, Hanna K.
Kauppinen, Risto A.
Coulthard, Elizabeth J.
author_facet Wearn, Alfie R.
Nurdal, Volkan
Saunders-Jennings, Esther
Knight, Michael J.
Madan, Christopher R.
Fallon, Sean-James
Isotalus, Hanna K.
Kauppinen, Risto A.
Coulthard, Elizabeth J.
author_sort Wearn, Alfie R.
collection PubMed
description A better understanding of early brain changes that precede loss of independence in diseases like Alzheimer's disease (AD) is critical for development of disease-modifying therapies. Quantitative MRI, such as T2 relaxometry, can identify microstructural changes relevant to early stages of pathology. Recent evidence suggests heterogeneity of T2 may be a more informative MRI measure of early pathology than absolute T2. Here we test whether T2 markers of brain integrity precede the volume changes we know are present in established AD and whether such changes are most marked in medial temporal lobe (MTL) subfields known to be most affected early in AD. We show that T2 heterogeneity was greater in people with mild cognitive impairment (MCI; n = 49) compared to healthy older controls (n = 99) in all MTL subfields, but this increase was greatest in MTL cortices, and smallest in dentate gyrus. This reflects the spatio-temporal progression of neurodegeneration in AD. T2 heterogeneity in CA1-3 and entorhinal cortex and volume of entorhinal cortex showed some ability to predict cognitive decline, where absolute T2 could not, however further studies are required to verify this result. Increases in T2 heterogeneity in MTL cortices may reflect localised pathological change and may present as one of the earliest detectible brain changes prior to atrophy. Finally, we describe a mechanism by which memory, as measured by accuracy and reaction time on a paired associate learning task, deteriorates with age. Age-related memory deficits were explained in part by lower subfield volumes, which in turn were directly associated with greater T2 heterogeneity. We propose that tissue with high T2 heterogeneity represents extant tissue at risk of permanent damage but with the potential for therapeutic rescue. This has implications for early detection of neurodegenerative diseases and the study of brain-behaviour relationships.
format Online
Article
Text
id pubmed-8350145
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Academic Press
record_format MEDLINE/PubMed
spelling pubmed-83501452021-09-01 T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment Wearn, Alfie R. Nurdal, Volkan Saunders-Jennings, Esther Knight, Michael J. Madan, Christopher R. Fallon, Sean-James Isotalus, Hanna K. Kauppinen, Risto A. Coulthard, Elizabeth J. Neuroimage Article A better understanding of early brain changes that precede loss of independence in diseases like Alzheimer's disease (AD) is critical for development of disease-modifying therapies. Quantitative MRI, such as T2 relaxometry, can identify microstructural changes relevant to early stages of pathology. Recent evidence suggests heterogeneity of T2 may be a more informative MRI measure of early pathology than absolute T2. Here we test whether T2 markers of brain integrity precede the volume changes we know are present in established AD and whether such changes are most marked in medial temporal lobe (MTL) subfields known to be most affected early in AD. We show that T2 heterogeneity was greater in people with mild cognitive impairment (MCI; n = 49) compared to healthy older controls (n = 99) in all MTL subfields, but this increase was greatest in MTL cortices, and smallest in dentate gyrus. This reflects the spatio-temporal progression of neurodegeneration in AD. T2 heterogeneity in CA1-3 and entorhinal cortex and volume of entorhinal cortex showed some ability to predict cognitive decline, where absolute T2 could not, however further studies are required to verify this result. Increases in T2 heterogeneity in MTL cortices may reflect localised pathological change and may present as one of the earliest detectible brain changes prior to atrophy. Finally, we describe a mechanism by which memory, as measured by accuracy and reaction time on a paired associate learning task, deteriorates with age. Age-related memory deficits were explained in part by lower subfield volumes, which in turn were directly associated with greater T2 heterogeneity. We propose that tissue with high T2 heterogeneity represents extant tissue at risk of permanent damage but with the potential for therapeutic rescue. This has implications for early detection of neurodegenerative diseases and the study of brain-behaviour relationships. Academic Press 2021-09 /pmc/articles/PMC8350145/ /pubmed/34116150 http://dx.doi.org/10.1016/j.neuroimage.2021.118214 Text en © 2021 The Author(s). Published by Elsevier Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wearn, Alfie R.
Nurdal, Volkan
Saunders-Jennings, Esther
Knight, Michael J.
Madan, Christopher R.
Fallon, Sean-James
Isotalus, Hanna K.
Kauppinen, Risto A.
Coulthard, Elizabeth J.
T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment
title T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment
title_full T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment
title_fullStr T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment
title_full_unstemmed T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment
title_short T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment
title_sort t2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350145/
https://www.ncbi.nlm.nih.gov/pubmed/34116150
http://dx.doi.org/10.1016/j.neuroimage.2021.118214
work_keys_str_mv AT wearnalfier t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment
AT nurdalvolkan t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment
AT saundersjenningsesther t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment
AT knightmichaelj t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment
AT madanchristopherr t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment
AT fallonseanjames t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment
AT isotalushannak t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment
AT kauppinenristoa t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment
AT coulthardelizabethj t2heterogeneityasaninvivomarkerofmicrostructuralintegrityinmedialtemporallobesubfieldsinageingandmildcognitiveimpairment